References
- World Health Organization (WHO). Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016.
- UNITAID. Tuberculosis Diagnostics Technology Landscape 2017. Geneva: UNITAID; 2017.
- World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Geneva: World Health Organization; 2011.
- World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children. Geneva: World Health Organization; 2013.
- World Health Organization. Molecular Line Probe Assays for Rapid Screening of Patients at Risk for Multi-drug Resistant Tuberculosis (MDR-TB). Geneva: World Health Organization; 2008.
- World Health Organization. The Use of Molecular Line Probe Assay for the Detection of Resistance to Isoniazid and Rifampicin: Policy Update. Geneva: World Health Organization; 2016.
- Kostera J, Leckie G, Tang N, et al. Analytical and clinical performance characteristic of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Tuberculosis. 2016;101:137–143.
- Tang N, Frank A, Pahalawatta V, et al. Analytical and clinical performance of Abbott RealTime MTB, an assay for detection of Mycobacterium tuberculosis in pulmonary specimens. Tuberculosis. 2015;95:613–619.
- Qi C, Wallis C, Pahalawatta V, et al. Evaluation of the efficiency of the sample inactivation reagent in the Abbott RealTime MTB assay for inactivation of Mycobacterium tuberculosis. J Clin Microbiol. 2015;53:3001–3002.
- Hofman-Thiel S, Molodtsov N, Anonenka U, Hoffman H. Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF assays for direct detection of Mycobacterium tuberculosis complex and resistance markers in respiratory and extrapulmonary specimens. J Clin Microbiol. 2016;54:3022–3027.
- Tam KK, Leung KS, To SW, et al. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott RealTime MTB detection and RIF/INH resistance assay. Diagn Microbiol Infect Dis. 2017;89(2):118–124.
- Scott L, David A, Noble L, et al. Performance of the Abbott RealTime MTB and MTB RIF/INH assays in a Setting of high Tuberculosis and HIV coinfection in South Africa. J Clin Microbiol. 2017;55(8):2491–2501.
- Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48:229–237.
- World Health Organization. WHO Treatment Guidelines for Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2016.
- Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007–2009. Int J Tuberc Lung Dis. 2012;16:812–816.